Clinical Trials Browser

Phase 2 × Breast Neoplasms × lutetium Lu 177 dotatate × Clear all

NCT04529044 2025-10-30

177Lu-DOTATATE for the Treatment of Stage IV or Recurrent Breast Cancer

Phase 2 Not yet recruiting

Breast Neoplasms